Overview
Driven by federal mandates, data sharing is increasingly becoming the norm. To meet these mandates, researchers often rely on broad consent provisions to inform research participants that their data may be used in future studies, including studies that may go beyond the purpose and scope of the research for which the data was originally collected.
This webinar provides an overview of the concept of broad consent, situational and contextual examples of appropriate use, alternatives to broad consent, and ethical considerations in disclosure of secondary findings.
Cost
Members: $100
Nonmembers: $190
What Will I Learn?
- Define broad consent and analyze scenarios to provide context for use
- Present alternatives to broad consent
- Engage in conversation regarding the ethics of disclosing secondary findings
Audience
Ideal for IRB members, staff, and researchers.
Credits Offered
CE Credit
Participants will receive a certificate of attendance that documents up to 1.25 continuing education credit hours for their attendance at this webinar. Certificates of attendance are useful for obtaining CE credits from professional associations. Each association's guidelines for accepting CE credit hours (in-person or virtual) may differ. Please consult the appropriate association representative for information on if, and how many, CE credits from this PRIM&R webinar may be used.
CIP Credit
Course participants who hold the Certified IRB Professional (CIP®) credential may apply 1.25 continuing education credits towards CIP® recertification credit for this PRIM&R webinar. Please refer to the CIP® recertification guidelines for additional information.
Rachele Hendricks-Sturrup, DHSc, MSc, MA
Research Director of Real-World Evidence at the Duke-Margolis Center for Health Policy
Dr. Rachele Hendricks-Sturrup is the Research Director of Real-World Evidence at the Duke-Margolis Center for Health Policy. As a researcher, bioethicist, and policy practitioner, her work centers on addressing implementation and ethical, legal, and social implications issues at the intersection of health policy and innovation.